Wuhan Keqian BiologyLtd Balance Sheet Health
Financial Health criteria checks 5/6
Wuhan Keqian BiologyLtd has a total shareholder equity of CN¥3.9B and total debt of CN¥186.3M, which brings its debt-to-equity ratio to 4.8%. Its total assets and total liabilities are CN¥4.6B and CN¥714.7M respectively. Wuhan Keqian BiologyLtd's EBIT is CN¥305.0M making its interest coverage ratio -3.6. It has cash and short-term investments of CN¥1.5B.
Key information
4.8%
Debt to equity ratio
CN¥186.26m
Debt
| Interest coverage ratio | -3.6x |
| Cash | CN¥1.50b |
| Equity | CN¥3.90b |
| Total liabilities | CN¥714.71m |
| Total assets | CN¥4.62b |
Recent financial health updates
We Think Wuhan Keqian BiologyLtd (SHSE:688526) Can Stay On Top Of Its Debt
Jun 26
Wuhan Keqian BiologyLtd (SHSE:688526) Has A Rock Solid Balance Sheet
Mar 20Recent updates
We Think Wuhan Keqian BiologyLtd (SHSE:688526) Can Stay On Top Of Its Debt
Jun 26Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Stock Rockets 25% But Many Are Still Ignoring The Company
Apr 08Analysts Are More Bearish On Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Than They Used To Be
Apr 05Earnings Miss: Wuhan Keqian Biology Co.,Ltd Missed EPS By 25% And Analysts Are Revising Their Forecasts
Apr 03Wuhan Keqian BiologyLtd (SHSE:688526) Has A Rock Solid Balance Sheet
Mar 20Financial Position Analysis
Short Term Liabilities: 688526's short term assets (CN¥2.5B) exceed its short term liabilities (CN¥637.3M).
Long Term Liabilities: 688526's short term assets (CN¥2.5B) exceed its long term liabilities (CN¥77.4M).
Debt to Equity History and Analysis
Debt Level: 688526 has more cash than its total debt.
Reducing Debt: 688526's debt to equity ratio has increased from 0% to 4.8% over the past 5 years.
Debt Coverage: 688526's debt is well covered by operating cash flow (264.7%).
Interest Coverage: 688526 earns more interest than it pays, so coverage of interest payments is not a concern.